Innophos Holdings, Inc. (NASDAQ:IPHS) Stake Increased by CENTRAL TRUST Co

CENTRAL TRUST Co boosted its position in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) by 20.8% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 5,803 shares of the specialty chemicals company’s stock after buying an additional 1,000 shares during the period. CENTRAL TRUST Co’s holdings in Innophos Holdings were worth $255,000 as of its most recent filing with the SEC.

Receive News & Ratings for Innophos Holdings Inc. Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Other hedge funds have also recently added to or reduced their stakes in the company. Private Advisor Group LLC purchased a new stake in Innophos Holdings during the first quarter worth $200,000. Barings LLC purchased a new stake in Innophos Holdings during the first quarter worth $200,000. State of Alaska Department of Revenue boosted its stake in Innophos Holdings by 81.4% in the first quarter. State of Alaska Department of Revenue now owns 3,810 shares of the specialty chemicals company’s stock worth $205,000 after buying an additional 1,710 shares in the last quarter. Curbstone Financial Management Corp purchased a new stake in Innophos Holdings during the first quarter worth $208,000. Finally, GHP Investment Advisors Inc. purchased a new stake in Innophos Holdings during the first quarter worth $223,000. Institutional investors and hedge funds own 94.10% of the company’s stock.

Innophos Holdings, Inc. (IPHS) traded up 0.33% during trading on Friday, reaching $42.15. 72,175 shares of the company’s stock were exchanged. The stock has a 50-day moving average of $43.59 and a 200-day moving average of $47.35. The stock has a market capitalization of $816.70 million, a PE ratio of 18.09 and a beta of 0.86. Innophos Holdings, Inc. has a 52 week low of $37.02 and a 52 week high of $58.22.

Innophos Holdings (NASDAQ:IPHS) last posted its quarterly earnings data on Monday, May 1st. The specialty chemicals company reported $0.59 EPS for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.07. The company had revenue of $165.94 million for the quarter, compared to the consensus estimate of $168.11 million. Innophos Holdings had a return on equity of 14.11% and a net margin of 6.56%. The company’s quarterly revenue was down 12.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.66 EPS. On average, equities research analysts anticipate that Innophos Holdings, Inc. will post $2.49 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by [[site]] and is the sole property of of [[site]]. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at [[permalink]].

A number of analysts have recently weighed in on the stock. Sidoti upgraded shares of Innophos Holdings from a “neutral” rating to a “buy” rating in a report on Friday, May 26th. They noted that the move was a valuation call. Zacks Investment Research raised shares of Innophos Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. Finally, BidaskClub lowered shares of Innophos Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th.

Innophos Holdings Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.